Professor GU-Radiation Oncology, Tata Memorial Centre Mumbai. Marathoner. Just turned triathlete.
Mumbai
Joined November 2020
- Tweets2.7K
- Following95
- Followers3.3K
- Likes11K
Pinned Tweet
Some moments in any academic life are defining... One near the top is being invited to deliver the visiting prof grand rounds to the bright and curious minds of the @HarvardRadOnc residents!
Showered with love and warmth Hope you enjoyed as much as I did. 🙏🏼 @DrPaulNguyen
Our faculty, @VedangMurthy, was invited as a Visiting Professor by the @HarvardRadOnc, where he spoke on “Radiotherapy for Urological Cancers: Asking the Right Questions.”
We congratulate Dr. Murthy on this recognition & contribution to the global academic dialogue!
This! Low dose IO for bladder cancer.... Like the video if you like the topic!
🇮🇳 Team India is brewing up some competition at the Uromigos World Cup! ☕⚽🏆
It's Chai Pe Charcha time! From Mumbai to Cleveland, Team India is exploring whether low-dose immunotherapy could make cancer treatment more affordable and what it might mean for bladder cancer.
Cheers to the competition! ☕
🎥 : @shilpaonc & @adidhanawat | #UromigosLive
Vedang Murthy retweeted
Just in @EUplatinum 👉#APCCC2026 report on high-risk localised, locally advanced & recurrent #ProstateCancer: 133 experts from across the world👉Highlights risk-adapted care & evidence gaps for trials. @APCCC_ @PCF_Science @UroToday @OncoAlert 👉link: shorturl.at/YAcnY
Vedang Murthy retweeted
TBH I am not blaming the AI at all! It does what it does.
I speak from the audience's POV.
Steering it to make it beautiful and meaningful (for the listener) needs much more time and effort than making it the good old fashioned way!
The irony of it! 😀
AI-generated slides have taken over every conference.😴
Boxes inside boxes, microscopic text, arrows connecting everything to everything else
The message is hidden deeper than a pelvic node!
Quite a turn-off.
We need a pre-conference workshop just to read the slides.
Vedang Murthy retweeted
Excited to share our JAMA Oncology phase 2 trial of neoadjuvant SAbR for RCC with IVC tumor thrombus!
1-year RFS: 71.4%, meeting the prespecified criterion. Feasible with encouraging safety findings. Larger trials are next!
doi.org/10.1001/jamaoncol.20…
#KidneyCancer #RadOnc
Vedang Murthy retweeted
We are excited to announce a new strategic partnership between the GSRGT and Urology Times!
Together, we aim to advance education, share expert insights, and raise awareness of rare GU malignancies.
Stay tuned for more!
@SpiessPhilippe @drgaganprakash @npaesa @CMercinelli @AmerUrological @CAU_URO @JadChahoud @benristau @PGrivasMDPhD @spsutkaMD @LuisMedinaMD @herneygarcia @AndreaNecchi @apolo_andrea @VedangMurthy
@ARRODRIGUEZMD @montypal @UrogerliMD @dramandeeparora @CurtisPettaway1 @karima_oualla @UrologyTimes
Colleagues, The abstract submission deadline for 2027 ASCO GU Symposium is October 13 at 11:59 pm ET.
#GU27
Our committee looks forward to reviewing your work! All accepted abstracts will be published in the JCO supplement.@ASCO_pubs Submit today: asco.confex.com/asco/gucs202…
Vedang Murthy retweeted
Heartiest congratulations @VedangMurthy ! Incredibly proud to work with you.
Some moments in any academic life are defining... One near the top is being invited to deliver the visiting prof grand rounds to the bright and curious minds of the @HarvardRadOnc residents!
Showered with love and warmth Hope you enjoyed as much as I did. 🙏🏼 @DrPaulNguyen
Vedang Murthy retweeted
Capping off #ASTRO26 week with an HROP first! 🌎☢️
We were thrilled to welcome Professor @VedangMurthy as our 1st international visiting professor. A great way to close out a week of learning & collaboration in Boston.
Thank you for visiting and sharing your expertise with us!
Vedang Murthy retweeted
@VedangMurthy with secondary analysis of POP-RT using Artera MMAI. Intriguing results suggesting digital pathology + clinical variables could stratify risk of occult LN metastasis and benefit of pelvic RT
@ASTRO_org #ASTRO26
Vedang Murthy retweeted
This review, led by @DeepOnco of @royalmarsdenNHS, outlines global trends and the evolving diagnostics, treatment, and surveillance of #ProstateCancer: acsjournals.onlinelibrary.wi…
@PCaParker @AmarUKishan @VedangMurthy @nickva1 @alison_tree @APCCC_Lugano @ICR_London #PCAM
Vedang Murthy retweeted
🇧🇪✨ Morning Piet! I came here for an answer not for your Belgium beautifully balanced intellect.
Would you start now? And if so what?
And in most cases we could wait if the patient agrees, and it’s a stressful time for time, but as you know some people do develop symptomatic disease that can cause long term morbidity.
I would treat now and in this case with ADT and Enza (if patient in agreement) with recommended exercise and diet @Adam_Weiner535 (excellent post yesterday) and aim for intermittent therapy if a good response.
Hope all well
Vedang Murthy retweeted
What is T? My guess is diffuse marrow disease rather than nodal. Have seen this once before. Repeat PSMA PET after 4 wks of ARPI capitalising PSMA flare could be an option. Either ways not taking systemic therapy is not an option for long.
Vedang Murthy retweeted
Please see our letter @alison_tree @piet_ost in response to the recent Focal therapy paper in @EUplatinum
authors.elsevier.com/a/1nlq2…
@LondonProstate1 @mrsprostate @taimurShah @ASTRO_org @ESTRO_RT
#PSMA Case Conundrum
65y HR #prostatecancer, cT3a, iPSA-55.68, GS:5+4
SBRT 2018 36.25Gy+ 2y ADT 2020 (no Abi)
BCF + Local rec (Bx:GG4) 2024;
ReSBRT done
PSA Rising again12....24...60!
All PSMA and FDG PET are -ve
No Symptoms
Why wont PSMA/FDG light up?
Now what? Thoughts?